What’s Behind the Ivermectin Frenzy?

About a year into President Trump’s global trade war, China hasn’t just survived. It has emerged stronger than ever on the world stage. Keith Bradsher, the Beijing bureau chief for The New York Times, discusses the domination of China’s robot-powered superfactories and how the co ...  Show more

The war in Iran has created strong divisions among President Trump’s supporters. An anti-interventionist wing of the Republican coalition and some senior administration officials partial to Mr. Trump’s criticism of long overseas conflicts have quickly become uneasy about the war, ...  Show more

Robert is joined by Jamie Loftus to discuss Ivermectin.

The second of two episodes this week, taking a deep dive into the pharmaceutical industry.

Big drug companies have won plaudits for their work producing Covid vaccines within a year of the start of the pandemic. How much money are they making from them? And why are vacci ...

The first in an unfolding miniseries - The Vaccine - tracking the progress of those tackling this historic challenge. We'll be making sense of the latest developments as they happen, taking an inside look at the vaccine industry, and learning from ...

One of the most frightening, least understood aspects of the coronavirus pandemic is what’s come to be known as “long Covid.” Stories abound of young, healthy adults who experienced mild or asymptomatic coronavirus infections and recovered fairly quickly, only to experience an ...